Data released by the Centres for Disease Control and Prevention shows that reports of deaths, injuries after COVID vaccines have been administered has increased against the previous report.
The data included a total of 23,615 reports of deaths — an increase of 466 over the previous week — and 188,135 reports of serious injuries, including deaths, during the same time period — up 4,824 compared with the previous week.
Excluding “foreign reports” to VAERS, 753,482 adverse events, including 10,747 deaths and 70,746 serious injuries, were reported in the U.S. between Dec. 14, 2020, and Feb. 4, 2022.
READ ALSO: Sweden stops mandatory COVID-19 test, lifts restrictions
Of the 10,747 U.S. deaths reported as of Feb. 4, 18% occurred within 24 hours of vaccination, 23% occurred within 48 hours of vaccination and 60% occurred in people who experienced an onset of symptoms within 48 hours of being vaccinated.
In the U.S., 541.5 million COVID vaccine doses had been administered as of Feb. 4, including 318 million doses of Pfizer, 205 million doses of Moderna and 18 million doses of Johnson & Johnson (J&J).
Every Friday, VAERS publishes vaccine injury reports received as of a specified date. Reports submitted to VAERS require further investigation before a causal relationship can be confirmed. Historically, VAERS has been shown to report only 1% of actual vaccine adverse events.
READ ALSO: No COVID vaccine mandate for federal employees, Court insists
The most recent death involves a 7-year-old girl from Minnesota who died 11 days after receiving her first dose of Pfizer’s COVID vaccine when she was found unresponsive by her mother. An autopsy is pending.
According to the report, 68 teens suffered anaphylaxis, among 12- to 17-year-olds where the reaction was life-threatening, required treatment or resulted in death — with 96% of cases attributed to Pfizer’s vaccine. 629 reports of myocarditis and pericarditis with 617 cases attributed to Pfizer’s vaccine. 155 reports of blood clotting disorders, with all cases attributed to Pfizer.
Pfizer said in December 2021 that two doses of its Pfizer-BioNTech vaccine failed to generate a strong immune response during its clinical trial of children ages 2 to 4.